Impact Factor
3.16
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.70
1,389 total citations
h5-index
39
h5 depth signal
Cited share
50.1%
425 of 848
Total citations
1,389
Citation footprint
Metric signal
1.46
External metric anchor
Self-citation
4.1%
57 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,651
Italy
314
Germany
312
Canada
310
China
284
Citing Fields of Research
Urology
2,176
Prostate Cancer
1,171
Oncology
840
Kidney Diseases
274
Immunology
168
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
7,563
Articles tracked across the journal lifetime
Indexed publication set
848
425 cited publications
Last 12 months
368
30.7 publications/month
Open access share
18.8%
69 OA publications in the last year
Leading citing country
United States
1,651 citing publications
Leading citing field
Urology
2,176 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v7n1,Jan.-Feb. 2002-v7n6, Nov./Dec. 2002;v21n1, Jan./Feb. 2003-
v7n1,Jan.-Feb. 2002-v7n6, Nov./Dec. 2002;v21n1, Jan./Feb. 2003-
Active Coverage
Research Focus & Classification
Indexed Subjects
Urology
Prostate Cancer
Broad Categories
Neoplasms
Urology
Prostate Cancer
MeSH Descriptors
Genital Neoplasms, Male
Urologic Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1016/j.urolonc.2026.09.014
Open DOI
Incidence and predictors of prolonged opioid use following nephrectomy for renal cell carcinoma: A national claims-based study
03
DOI 10.1016/j.urolonc.2026.09.015
Open DOI
Restricted mean survival time-based network meta-analysis of first-line therapies for metastatic clear cell renal cell carcinoma
04
DOI 10.1016/j.urolonc.2026.09.018
Open DOI
Project international Delphi consensus recommendations for perioperative management of inguinal lymphadenectomy in cancer patients
05
06
DOI 10.1016/j.urolonc.2026.09.013
Open DOI
Comparing patient-reported urinary and sexual bother and function after robotic-assisted radical prostatectomy
07
DOI 10.1016/j.urolonc.2026.09.016
Open DOI
Response to “Calendar-time bias in a TriNetX study of GLP-1 receptor agonists, SGLT2 inhibitors and bladder cancer survival”
08
09
DOI 10.1016/j.urolonc.2026.09.008
Open DOI
Translational research models for variant subtype bladder cancers: A comprehensive review of the current landscape
10
Bibliographical & Catalog Notes
Vols. for Jan./Feb. 2003- have subtitle: Seminars and original investigations.
Place of publication varies.
Description based on: Vol. 2, no. 4 (July/Aug 1996); title from cover.
Latest issue consulted: surrogate of Vol. 21, no. 1 (Jan./Feb. 2003).
No issues published in 1999.
Vols. for Jan./Feb. 2003- called Vol. 21, no. 1- , continuing the numbering of Seminars in urologic oncology, which it absorbed in 2003.
Also issued online.
Absorbed: Seminars in urologic oncology.